Autopsy report · NCT00972218

Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease

“Difficulty with enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

University of Alberta

Sponsor type

University, hospital or other

Conditions

Spondyloarthritis; Crohn's Disease

Interventions

Adalimumab

Participants

0

Sites

1

Countries

Canada

Trials that died the same way

• A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy
  “difficulty in enrollment” (98% match in meaning)
• Maintenance Dosing of Vitamin D in Crohn's Disease
  “Difficulties with enrollment” (98% match in meaning)
• AVAD: Asthma With Small Airways Dysfunction
  “difficulties of enrollment” (93% match in meaning)
• Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT)
  “difficult enrollment” (93% match in meaning)
• Clinical Trial With Mesalamine 1g Suppositories
  “Enrollment difficulties” (93% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.